Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 272

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 272
---
 all such securities are anti-dilutive.

The loss and the weighted average number
of shares used in computing basic and diluted net loss per share is as follows:

|                                                        |     | Year ended   
 December 31, 
 2023         |        |   |     | 2022 |        |   |
|:-------------------------------------------------------|:----|:-------------|-------:|:--|:----|:-----|-------:|:--|
| Numerator:                                             |     |              |        |   |     |      |        |   |
| Net loss                                               |     |              | (4,132 | ) |     | $    | (1,449 | ) |
| Interest accrued on convertible preferred shares       |     |              |    (48 | ) |     |      |    (48 | ) |
| Net loss attributed to ordinary shares                 |     |              | (4,180 | ) |     |      | (1,497 | ) |
| Denominator:                                           |     |              |        |   |     |      |        |   |
| Ordinary shares                                        |     |              | 64,879 |   |     |      | 64,879 |   |
| Warrants                                               |     |              |  4,524 |   |     |      |      - |   |
| Weighted-average shares outstanding, basic and diluted |     |              | 69,403 |   |     |      | 64,879 |   |
| Net loss per share, basic and diluted                  |     |              |  (60.2 | ) |     |      |  (22.0 | ) |

On August 15, 2023, the Company issued
11,965 warrants (please refer to Note 11). The warrants were considered exercisable for little to no consideration and are therefore
included in basic shares outstanding at their issuance date.

| n. | Accounting pronouncement recently adopted |

In February 2016, the FASB issued ASU
2016-02 “Leases” to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. For operating leases, the ASU requires a lessee to recognize
a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, on its balance sheet. The ASU
retains the current accounting for lessors and does not